Expression of p120 nucleolar proliferating antigen in human gliomas and growth suppression of glioma cells by p120 ribozyme vector

International Journal of Oncology

Volumn 14, Issue 3, 1999, Pages 417-424

  Sato, Kyoichi ^a   Nishi, Toru ^a,c   Takeshima, Hideo ^a   Kochi, Masato ^a   Kuratsu, Jun Ichi ^a   Masuko, Norio ^b   Sugimoto, Yoshikazu ^b   Yamada, Yuji ^b   Ushio, Yukitaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell cycle; Glioma; Northern blot; p120; Ribozyme; Western blot

Indexed keywords

MESSENGER RNA; NOL1 PROTEIN, HUMAN; NUCLEAR PROTEIN; RIBOZYME;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; GLIOMA; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY;

BASE SEQUENCE; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; GLIOMA; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RNA, CATALYTIC; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033092206     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.3.417     Document Type: Article

References (28)

1. Busch H: The final common pathway of cancer: presidential address. Cancer Res 50: 4830-4838, 1990.
2. Ochs RL, Reilly MT, Freeman JW and Busch H: Intranucleolar localization of human proliferating cell nucleolar antigen p120. Cancer Res 48: 6523-6529, 1988.
3. Fonagy A, Henning D, Jhiang S, Haidar M, Busch RK, Larson R, Valdez B and Busch H: Cloning of the cDNA and sequence of the human proliferating-cell nucleolar protein P120. Cancer Commun 1: 243-251, 1989.
4. Larson RG, Henning D, Haidar MA, Jhiang S, Lin WL, Zhang WW and Busch H: Genomic structure of the human proliferating cell nucleolar protein P120. Cancer Commun 2: 63-71, 1990.
5. Nakayama UT, Sugao Y, Kohno K, Matsuo K, Sugimoto Y, Yamada Y, Kuwano M and Tsuneyoshi M: Significance of the expression of proliferation-associated nucleolar antigen p120 in human cororectal tumors. Hum Pathol 28: 74-79, 1997.
6. Perlaky L, Valdez BC, Busch RK, Larson RG, Jhiang SM, Zhang WW, Brattain M and Busch H: Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct. Cancer Res 52: 428-436, 1992.
7. Freeman JW, McGrath P, Bondada V, Selliah N, Ownby H, Maloney T, Busch RK and Busch H: Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma. Cancer Res 51: 1973-1978, 1991.
8. McGrath PC, Holley DT, Hamby LS, Powell DE, Mattingly C and Freeman JW: Proliferation-associated nucleolar antigen P120: a prognostic marker in node-negative breast cancer. Surgery 116: 616-621, 1994.
9. Glinski B: Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant glioma. A preliminary report on a randomized trial. J Neurooncol 16: 167-172, 1993.
10. Weller M, Malipiero U, Rensing-Ehl A, Barr PJ and Fontana A: Fas/apo-1 gene transfer for human malignant glioma. Cancer Res 55: 2936-2944, 1995.
11. Freeman JW, Busch RK, Gyorkey F, Gyorkey P, Ross BE and Busch H: Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early Gl phase. Cancer Res 48: 1244-1251, 1988.
12. Potter PM, Harris LC, Remack JS, Edwards CC and Brent TP: Ribozyme-mediated modulation of human O6-methylguanine-DNA methyltransferase expression. Cancer Res 53: 1731-1734, 1993.
13. Kashani-Sabet M, Funato T, Florenes VA, Fodstad O and Scanlon KJ: Suppression of the neoplastic phenotype in vivo by anti-ras ribobyme. Cancer Res 54: 900-902, 1994.
14. Feng M, Cabrera G, Deshane J, Scanlon KJ and Curiel DT: Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res 55: 2024-2028, 1995.
15. Shore SK, Nabissa PM and Reddy EP: Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity. Oncogene 8: 3183-3188, 1993.
16. Bocker T, Bittinger A, Wieland W, Buettner R, Fauser G, Hofstaedter F and Ruschoff J: In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate. Mod Pathol 8: 226-231, 1995.
17. Fonagy A, Swiderski C and Freeman JW: Nucleolar p120 is expressed as a delayed early response gene and is inducible by DNA-damaging agents. J Cell Physiol 164: 634-643, 1995.
18. Fonagy A, Swiderski C and Freeman JW: Altered transcription control is responsible for the increased level of proliferation-associated p120 in rapidly growing breast carcinoma. Int J Cancer 60: 407-412, 1995.
19. Fonagy A, Swiderski C, Wilson A, Bolton W, Kenyon N and Freeman JW: Cell cycle regulated expression of nucleolar antigen P120 in normal and transformed human fibroblasts. J Cell Physiol 154: 16-27, 1993.
20. Gorczyca W, Bruno S, Melamed MR and Darzynkiewicz Z: Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: effects of methotrexate, camptothecin, and teniposide. Cancer Res 52: 3491-3494, 1992.
21. Fonagy A, Swiderski C, Dunn M and Freeman JW: Antisense-mediated specific inhibition of P120 protein expression prevents G1- to S-phase transition. Cancer Res 52: 5250-5256, 1992.
22. Wilson A and Freeman JW: Regulation of p120 mRNA levels during lymphocyte stimulation: evidence that the p120 gene shares properties with early and late genes. J Cell Biochem 60: 458-468, 1996.
23. Bolton WE, Freeman JW, Mikulka WR, Healy CG, Schmittling RJ and Kenyon NS: Expression of proliferation-associated antigens (PCNA, p120, p145) during the reentry of GO cells into the cell cycle. Cytometry 17: 66-74, 1994.
24. Perlaky L, Smetana K, Busch RK, Saijo Y and Busch H: Nucleolar and nuclear aberrations in human lox tumor cells following treatment with p120 antisense oligonucleotide ISIS-3466. Cancer Lett 74: 125-135, 1993.
25. Jhiang SM, Yaneva M and Busch H: Expression of human proliferation-associated nucleolar antigen p120. Cell Growth Differ 1: 319-324, 1990.
26. Koonin EV: Prediction of an rRNA methyltransferase domain in human tumor-specific nucleolar protein P120. Nucleic Acids Res 22: 2476-2478, 1994.
27. Perlaky L, Busch RK and Busch H: Combinatorial effects of monoclonal anti-p120 antibody(MAbp120), liposomes and hyperthermia on MCF-7 and LOX tumor cell lines. Oncol Res 8: 363-369, 1996.
28. Saijo Y, Perlaky L, Valdez BC, Busch RK, Henning D, Zhang WW and Busch H: The effect of antisense p120 construct on p120 expression and cell proliferation in human breast cancer MCF-7 cells. Cancer Lett 68: 95-104, 1993.